90
Views
22
CrossRef citations to date
0
Altmetric
Articles

Diffusion of Cefepime into Cancellous and Cortical Bone Tissue

Pages 134-138 | Published online: 18 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Concepcion Perez-Jorge, Enrique Gomez-Barrena, Juan-Pablo Horcajada, Lluis Puig-Verdie & Jaime Esteban. (2016) Drug treatments for prosthetic joint infections in the era of multidrug resistance. Expert Opinion on Pharmacotherapy 17:9, pages 1233-1246.
Read now
Andrea Endimiani, Federico Perez & Robert A Bonomo. (2008) Cefepime: a reappraisal in an era of increasing antimicrobial resistance. Expert Review of Anti-infective Therapy 6:6, pages 805-824.
Read now

Articles from other publishers (20)

M. Lacasse, S. Derolez, E. Bonnet, A. Amelot, B. Bouyer, R. Carlier, G. Coiffier, J.P. Cottier, A. Dinh, I. Maldonado, F. Paycha, J.M. Ziza, P. Bemer, L. Bernard, Géraldine Bart, Pascal Coquerelle, Stéphane Corvec, Anne Cotten, Marion Couderc, E. Denes, Arnaud Dupeyron, Sophie Godot, Marion Grare, A. Homs, Brigitte Lam, Jean Philippe Lavigne, V. Lemoing, Edouard Pertuiset, P. Ribinik, France Roblot, Eric Senneville, Jean Philippe Talarmin, I. Tavares Figueiredo, Marie Titeca & Valérie Zeller. (2023) 2022 SPILF - Clinical Practice guidelines for the diagnosis and treatment of disco-vertebral infection in adults. Infectious Diseases Now 53:3, pages 104647.
Crossref
Stefano Finazzi, Giacomo Luci, Carlo Olivieri, Martin Langer, Giulia Mandelli, Alberto Corona, Bruno Viaggi & Antonello Di Paolo. (2022) Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review—Part I. Antibiotics 11:9, pages 1164.
Crossref
Melissa Depypere, Jonathan Sliepen, Jolien Onsea, Yves Debaveye, Geertje A. M. Govaert, Frank F. A. IJpma, Werner Zimmerli & Willem-Jan Metsemakers. (2022) The Microbiological Etiology of Fracture-Related Infection. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Gwendolyn M. Pais, Jack Chang, Erin F. Barreto, Gideon Stitt, Kevin J. Downes, Mohammad H. Alshaer, Emily Lesnicki, Vaidehi Panchal, Maria Bruzzone, Argyle V. Bumanglag, Sara N. Burke & Marc H. Scheetz. (2022) Clinical Pharmacokinetics and Pharmacodynamics of Cefepime. Clinical Pharmacokinetics 61:7, pages 929-953.
Crossref
Benjamin Le Vavasseur & Valérie Zeller. (2022) Antibiotic Therapy for Prosthetic Joint Infections: An Overview. Antibiotics 11:4, pages 486.
Crossref
Rachel Subramanian & Lynn Fitzgibbons. (2022) Burkholderia cepacia Complex Lumbar Spondylodiscitis: A Rare Nosocomial Infection. Case Reports in Infectious Diseases 2022, pages 1-4.
Crossref
O. Robineau, E. Talagrand-Reboulh, B. Brunschweiler, F. Jehl, E. Beltrand, F. Rousseau, N. Blondiaux, A. Grillon, C. Joseph, P. Lambotte, P. Boyer & Eric Senneville. (2021) Low prevalence of tissue detection of cefepime and daptomycin used as empirical treatment during revision for periprosthetic joint infections: results of a prospective multicenter study. European Journal of Clinical Microbiology & Infectious Diseases 40:11, pages 2285-2294.
Crossref
Cornelia B. Landersdorfer, Jürgen B. Bulitta, Roger L. Nation & Fritz Sörgel. 2021. Bone and Joint Infections. Bone and Joint Infections 81 98 .
Abrar K. Thabit, Dania F. Fatani, Maryam S. Bamakhrama, Ola A. Barnawi, Lana O. Basudan & Shahad F. Alhejaili. (2019) Antibiotic penetration into bone and joints: An updated review. International Journal of Infectious Diseases 81, pages 128-136.
Crossref
Samit Kumar Nandi, Samiran Bandyopadhyay, Piyali Das, Indranil Samanta, Prasenjit Mukherjee, Subhasis Roy & Biswanath Kundu. (2016) Understanding osteomyelitis and its treatment through local drug delivery system. Biotechnology Advances 34:8, pages 1305-1317.
Crossref
O. Grossi, N. Asseray, C. Bourigault, S. Corvec, M. Valette, D. Navas, L. Happi-Djeukou, S. Touchais, P. Bémer & D. Boutoille. (2016) Gram-negative prosthetic joint infections managed according to a multidisciplinary standardized approach: risk factors for failure and outcome with and without fluoroquinolones. Journal of Antimicrobial Chemotherapy 71:9, pages 2593-2597.
Crossref
Nikolas J. Onufrak, Alan Forrest & Daniel Gonzalez. (2016) Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing. Clinical Therapeutics 38:9, pages 1930-1947.
Crossref
Cornelia B. Landersdorfer, Jürgen B. Bulitta & Fritz Sörgel. 2015. Bone and Joint Infections. Bone and Joint Infections 21 37 .
P.N.A. Harris & J.K. Ferguson. (2012) Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?. International Journal of Antimicrobial Agents 40:4, pages 297-305.
Crossref
B. Spellberg & B. A. Lipsky. (2011) Systemic Antibiotic Therapy for Chronic Osteomyelitis in Adults. Clinical Infectious Diseases 54:3, pages 393-407.
Crossref
Michael PfallerAndrea Endimiani & David Paterson. 2010. Kucers' The Use of Antibiotics Sixth Edition. Kucers' The Use of Antibiotics Sixth Edition 427 441 .
Cornelia B. Landersdorfer, Martina Kinzig, Jürgen B. Bulitta, Friedrich F. Hennig, Ulrike Holzgrabe, Fritz Sörgel & Johannes Gusinde. (2009) Bone Penetration of Amoxicillin and Clavulanic Acid Evaluated by Population Pharmacokinetics and Monte Carlo Simulation. Antimicrobial Agents and Chemotherapy 53:6, pages 2569-2578.
Crossref
Cornelia B. Landersdorfer, Jürgen B. Bulitta, Martina Kinzig, Ulrike Holzgrabe & Fritz Sörgel. (2009) Penetration of Antibacterials into Bone. Clinical Pharmacokinetics 48:2, pages 89-124.
Crossref
Jason A. Roberts, Steven A.R. Webb & Jeffrey Lipman. (2007) Cefepime versus ceftazidime: considerations for empirical use in critically ill patients. International Journal of Antimicrobial Agents 29:2, pages 117-128.
Crossref
L. Legout, E. Senneville, R. Stern, Y. Yazdanpanah, C. Savage, M. Roussel-Delvalez, B. Rosele, H. Migaud & Y. Mouton. (2006) Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime–fluoroquinolone combination. Clinical Microbiology and Infection 12:10, pages 1030-1033.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.